drugset / Trial / NCT01418729
Efficacy and Safety Study of Sorafenib Plus Pravastatin to Treat Advanced Hepatocarcinoma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the overall survival (OS) in order to assess the efficacy and safety of pravastatin as adjuvant treatment to sorafenib.
Timeline
- Start
- 2011-09
- Primary completion
- 2015-12
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pravastatin | Small molecule | 40 mg | — |